1,1'-Carbonylbis-1H-imidazol

1,1'-Carbonyldiimidazole

HCID 68263CAS 530-62-1

Grundinformationen

Standard-SMILES
O=C(n1ccnc1)n1ccnc1
InChIKey
PFKFTWBEEFSNDU-UHFFFAOYSA-N
Summenformel
C7H6N4O
Durchschnittliche Molmasse
162,15 g/mol
Monoisotopische Masse
162,05416083

Namen und Bezeichner

Bevorzugter Name
1,1'-Carbonyldiimidazole
IUPAC
di(imidazol-1-yl)methanone
Lokaler Name
1,1'-Carbonylbis-1H-imidazol
Englischer Name
1,1'-Carbonyldiimidazole
Summenformel
C7H6N4O
Molmasse
162.15

Namen und Synonyme

530-62-11,1'-CarbonyldiimidazoleN,N'-CarbonyldiimidazoleN,N-CarbonyldiimidazoleCarbonyl diimidazoleDiimidazol-1-yl ketone63A10X1FSPNSC-67203RefChem:821863208-488-9di(1H-imidazol-1-yl)methanoneCarbonyldiimidazole
Weitere Namen anzeigen
CDI1,1'-CARBONYLDIIMIDAZOLE (CDI)1,1-CARBONYL DIIMIDAZOLEDiimidazolyl ketoneDi-imidazol-1-yl-methanoneCARBODIIMIDAZOLE
1H-Imidazole, 1,1'-carbonylbis-1,1'-Carbonylbis-1H-imidazole1,1-Carbonyldiimidazoledi(imidazol-1-yl)methanone1-(1H-imidazole-1-carbonyl)-1H-imidazoleCDI CrosslinkerN,N'-Carbonylbis(imidazole)1-Oxomethylenebis(N-imidazole)

Datenbank-Bezeichner

CAS
530-62-1
PubChem CID
68263
DTXSID
DTXSID9038761
ChEMBL
CHEMBL3903881
UNII
63A10X1FSP
EC Number
208-488-9
Nikkaji
J182.298E

Eigenschaften

Berechnete Struktureigenschaften

XLogP
-0,2
Polarare Oberfläche (TPSA)
52,7 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
0
Schwere Atome
12

Experimentelle und physikochemische Eigenschaften

Physical DescriptionSolid; [Merck Index] White crystalline powder; [Alfa Aesar MSDS]

Physikochemische Eigenschaften

Schmelzpunkt
117 · 117-122 °C(lit.)
Siedepunkt
288.83 °C · 288.83°C (rough estimate)
Dichte
1.303 g/mL · 1.303 g/mL at 25 °C
Dampfdruck
0.006 · 0.006-0.012Pa at 20-25℃
Brechungsindex
20 · n20/D1.434
storage temp.
2 · 2-8°C

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 6 Einträge

This chemical does not meet GHS hazard criteria for 0.4% (1 of 233) of reports.

Danger

H302 (84.1%): Harmful if swallowed [Warning Acute toxicity, oral];H314 (83.3%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation];H315 (15.9%): Causes skin irritation [Warning Skin corrosion/irritation];H318 (45.9%): Causes serious eye damage [Danger Serious eye damage/eye irritation];H319 (15.9%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H360 (26.2%): May damage fertility or the unborn child [Danger Reproductive toxicity];H360D (16.3%): May damage the unborn child [Danger Reproductive toxicity]

P203, P260, P264, P264+P265, P270, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P351+P338, P305+P354+P338, P316, P317, P318, P321, P330, P332+P317, P337+P317, P362+P364, P363, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 233 reports by companies from 28 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Reported as not meeting GHS hazard criteria per 1 of 233 reports by companies.;There are 27 notifications provided by 232 of 233 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Gefahrenhinweise

Regulatory Information · 3 Einträge

Chemical: 1H-Imidazole, 1,1'-carbonylbis-

Status: Active Update: 30-03-2023 https://echa.europa.eu/registration-dossier/-/registered-dossier/10364

1,1'-Carbonyldiimidazole: Does not have an individual approval but may be used under an appropriate group standard

Hazards SummaryHydrolyzed by water evolving carbon dioxide; [Merck Index] Causes burns; Inhalation may cause corrosive injuries to upper respiratory tract and lungs; Harmful by ingestion; [Alfa Aesar MSDS]
Hazard Classes and CategoriesAcute Tox. 4 (84.1%);Skin Corr. 1B (83.3%);Skin Irrit. 2 (15.9%);Eye Dam. 1 (45.9%);Eye Irrit. 2 (15.9%);Repr. 1B (26.2%);Repr. 1B (16.3%)

Toxikologische Informationen

Adverse EffectsDermatotoxin - Skin burns.;Toxic Pneumonitis - Inflammation of the lungs induced by inhalation of metal fumes or toxic gases and vapors.

Regulatorische Informationen

Regulatory Information · 3 Einträge

Chemical: 1H-Imidazole, 1,1'-carbonylbis-

Status: Active Update: 30-03-2023 https://echa.europa.eu/registration-dossier/-/registered-dossier/10364

1,1'-Carbonyldiimidazole: Does not have an individual approval but may be used under an appropriate group standard

Sicherheitsdaten

F
10-21
wgk
2
tsca
TSCA listed
ridadr
UN 3263 8/PG 2
hs_code
29332990
risk_code
22-34-36/37/38-40-36/38

Chemie und Industrie

Verwendung und Herstellung

UsesUsed to make peptides; [Merck Index]
General Manufacturing InformationMethanone, di-1H-imidazol-1-yl-: ACTIVE
Anwendungen · 1 Eintrag

VerwendenCDI, also known as 1,1'-carbonyldiimidazole, is a commonly used peptide coupling reagent in the synthesis of peptides and nucleoside triphosphates. It usually contains approximately 10% imidazole and reacts rapidly with carboxylic acids to produce acyl imidazoles. Later, it readily reacts with amines to create amides. In addition, CDI is useful in converting alcohols and amines into a range of chemical compounds, including carbamates, esters, and ureas.

Darstellung · 1 Eintrag

synthetische1,1'-Carbonyldiimidazole has been prepared by the reaction of imidazole and phosgene in anhydrous benzene and anhydrous tetrahydrofuran. It has also been obtained by the reaction of 1-(trimethylsilyl)imidazole and phosgene in anhydrous benzene, but that method offers no advantages that justify the more extensive preparative effort required.DOI: 10.15227/orgsyn.048.0044

Anbieter50 Anbieter

国药集团化学试剂有限公司86-21-63210123 · [email protected]
北京华美互利生物化工010-56205725 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
INTATRADE GmbH+49 3493/605464 · [email protected]

Zugehörige Reaktionen

9.856

Verknüpfte Notizen

Wird geladen…